Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4390001 | 4193104 | I | 4390001-4 | 20040614 | 20040616 | 20040630 | EXP | A-CH2004-06615 | ACTELION PHARMACEUTICALS US, INC | 71 | YR | F | N | 50 | KG | 20040629 |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4390001 | 1004988339 | PS | TRACLEER | 1 | ORAL | 62.5 MG, BID, ORAL | Y | D | 21290 | ||
| 4390001 | 1005006430 | C | RIFAMPICIN | 1 | |||||||
| 4390001 | 1005006431 | C | PYOSTACINE (PRISTINAMYCIN) | 2 | |||||||
| 4390001 | 1005006433 | C | VANCOMYCIN | 1 | |||||||
| 4390001 | 1005006434 | C | ACETAMINOPHEN | 1 | |||||||
| 4390001 | 1005006435 | C | OMEPRAZOLE | 1 | |||||||
| 4390001 | 1005006436 | C | CALCIDOSE (CALCIUM CARBONATE) | 2 | |||||||
| 4390001 | 1005006437 | C | PREDNISONE TAB | 1 | |||||||
| 4390001 | 1005006438 | C | PRAXILENE (NAFIDROFURYL OXALATE) | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4390001 | 1004988339 | PULMONARY HYPERTENSION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4390001 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 4390001 | ALANINE AMINOTRANSFERASE INCREASED |
| 4390001 | ASPARTATE AMINOTRANSFERASE INCREASED |
| 4390001 | TRANSAMINASES INCREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4390001 | FGN |
| 4390001 | HP |
| 4390001 | OTH |
| 4390001 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4390001 | 1004988339 | 20040517 | 20040614 |